ibi101
Showing 1 - 1 of 1
Advanced Solid Tumor Trial in Guangzhou (IBI101, Sintilimab)
Active, not recruiting
- Advanced Solid Tumor
- IBI101
- Sintilimab
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Aug 16, 2021